Menu

Cancer

Two Papers From a Large Multi-site Study Further Demonstrate Efficacy and Quality of Life Benefits for Prostate Cancer Patients Treated with Accuray’s CyberKnife® System

, , , ,

UCLA Researchers Evaluate Long-term Outcomes of More than 1,000 Patients from Multiple Institutions SUNNYVALE, Calif., November 7, 2013 – Accuray Incorporated (Nasdaq: ARAY), announced today the publication of two papers stemming from a large multi-center study of CyberKnife® stereotactic body radiotherapy (SBRT) led by investigators at the University of California, Los Angeles (UCLA). The first […]

New Study Finds Robotic-Assisted Lung Surgery Offers Improved Patient Outcomes Compared to Open Surgery

, , , , ,

SUNNYVALE, Calif., Nov. 4, 2013 (GLOBE NEWSWIRE) — A new study comparing open surgery, video-assisted thoracic surgery (VATS), and robotic-assisted surgery to remove diseased lung tissue found that robotic-assisted surgery is associated with significantly lower death rates, lower overall complication rates, and shorter hospital stays compared with open surgery. Researchers also concluded that robotic-assisted surgery is an […]

Elekta appoints Niklas Savander as its next President and Chief Executive Officer

, , , ,

Stockholm, October 25 – Elekta announced today that Niklas Savander has been appointed as its next President and Chief Executive Officer, effective May 1, 2014. Niklas Savander will succeed Tomas Puusepp, who will continue with Elekta as a working member of its Board of Directors focusing on strategic matters and market-developments per the same date. […]

Two New Analyses Demonstrate That Robotic-Assisted Surgery Results in Fewer Complications Compared With Open Surgery for Urologic Cancers

, , , , ,

SUNNYVALE, Calif., Oct. 24, 2013 (GLOBE NEWSWIRE) — In two independent analyses comparing robotic-assisted surgery and open surgery performed on patients with urologic cancers, researchers found that robotic-assisted surgery results in fewer overall complications during and after surgery, less blood loss and shorter length of hospital stay. In the first analysis, which was published in this month’s […]

FDA Grants Lilly’s Ramucirumab Priority Review as a Potential Single-Agent Treatment for Advanced Gastric Cancer

, , , ,

INDIANAPOLIS, Oct. 23, 2013 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has assigned Priority Review to the regulatory submission for ramucirumab (IMC-1121B) as a single-agent treatment for advanced gastric cancer following disease progression after initial chemotherapy. “We are very pleased that the FDA has […]

More than 100 Presentations at Leading Radiation Oncology Meeting Demonstrate High Value and Broad Utilization of Accuray’s Treatment Platforms

, , , ,

Data Supports Growing Use of CyberKnife® SBRT for Prostate Cancer SUNNYVALE, Calif., October 3, 2013 and ASTRO 2013 (Atlanta)– Accuray Incorporated (Nasdaq: ARAY) announced today that studies presented at the 55th Annual American Society for Radiation Oncology (ASTRO) Meeting in Atlanta, September 22 – 25, 2013 continue to reinforce evidence of clinical and quality of life benefits for […]

Nucletron, an Elekta Company, Receives US FDA 510(k) Clearance for Esteya Electronic Brachytherapy System for Treating Skin Cancer

, , , ,

Stockholm, October 2 – Esteya®, an electronic brachytherapy system, has received 510(k) clearance from the US Food and Drug Administration (FDA), enabling medical centers in the United States to offer their patients with skin cancer a new treatment option. Esteya is a new approach for high precision skin cancer treatment. The system relies on a small […]

Elekta Opens Global Education Center for Oncology and Neuroscience Professionals

, , , ,

Learning and Innovation Center (LINC) to draw thousands to Atlanta ATLANTA, Sept. 23 – Elekta will unveil a state-of-the-art learning center at its North American headquarters, in conjunction with the 55th Annual Meeting of the American Society for Radiation Oncology (ASTRO) being held in Atlanta. The Learning and Innovation Center (LINC) is expected to draw […]

«‹ 3 4 5 6›»